30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Cowan Elvia

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cowan Elvia's trades of Vaxcyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-08 2026-04-07
US Vaxcyte Inc (PCVX)
PlS Planned sale
51,356 -47.8%
409.94
US$1,769,646 		51,356 -47.8% 409.94 US$1,769,646
2026-04-07 2026-04-07
US Vaxcyte Inc (PCVX)
PrS Proposed sale
19,177
359.28
US$408,641 		19,177 359.28 US$408,641
2026-03-18 2026-03-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
72,263 -16.7%
41.78
US$4,559,311 		72,263 -16.7% 41.78 US$4,559,311
2026-03-18 2026-03-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,487 -4.8%
55.39
US$82,360 		1,487 -4.8% 55.39 US$82,360
2026-03-17 2026-03-17
US Vaxcyte Inc (PCVX)
PrS Proposed sale
1,892
55.89
US$105,744 		1,892 55.89 US$105,744
2026-03-11 2026-03-11
US Vaxcyte Inc (PCVX)
PrS Proposed sale
2,500
58.62
US$146,550 		2,500 58.62 US$146,550
2026-03-11 2026-03-11
US Vaxcyte Inc (PCVX)
PlS Planned sale
2,500 -7.5%
58.59
US$146,482 		2,500 -7.5% 58.59 US$146,482
2025-12-29 2025-12-23
US Vaxcyte Inc (PCVX)
S Sale
6,716 -31.6%
47.94
US$321,931 		6,716 -31.6% 47.94 US$321,931
2025-12-29 2025-12-23
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,907 -18.8%
47.90
US$235,040 		4,907 -18.8% 47.90 US$235,040
2025-12-23 2025-12-23
US Vaxcyte Inc (PCVX)
PrS Proposed sale
11,623
47.92
US$556,972 		11,623 47.92 US$556,972
2024-09-05 2024-09-03
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -28.2%
107.67
US$538,350 		5,000 -28.2% 107.67 US$538,350
2024-09-03 2024-09-03
US Vaxcyte Inc (PCVX)
PrS Proposed sale
5,000
107.67
US$538,350 		5,000 107.67 US$538,350
2024-07-17 2024-07-16
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -28.2%
85.00
US$425,000 		5,000 -28.2% 85.00 US$425,000
2024-07-16 2024-07-16
US Vaxcyte Inc (PCVX)
PrS Proposed sale
5,000
85.00
US$425,000 		5,000 85.00 US$425,000
2024-07-09 2024-07-08
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -28.2%
80.00
US$400,000 		5,000 -28.2% 80.00 US$400,000
2024-07-08 2024-07-08
US Vaxcyte Inc (PCVX)
PrS Proposed sale
5,000
80.00
US$400,000 		5,000 80.00 US$400,000
2024-03-04 2024-03-01
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,901 -28.2%
74.90
US$367,085 		4,901 -28.2% 74.90 US$367,085
2024-03-04 2024-03-01
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,455 -20.4%
73.69
US$328,284 		4,455 -20.4% 73.69 US$328,284
2024-03-04 2024-03-01
US Vaxcyte Inc (PCVX)
PlS Planned sale
2,322 -9.6%
73.08
US$169,701 		2,322 -9.6% 73.08 US$169,701
2024-03-01 2024-03-01
US Vaxcyte Inc (PCVX)
PrS Proposed sale
11,678
74.57
US$870,828 		11,678 74.57 US$870,828